Virginia Economic Review

Medical Device Manufacturer Embody Sets Stage for International Growth For Norfolk-based Embody, Inc., the six-year process of product development, preclinical testing, and compliance hurdles to get its collagen-based tendon and ligament implant, Tapestry, into the U.S.

Partnership With JMU, BRCC Helps Merck Fill Need for HPV Vaccines In 2019, Melissa Lubin learned that pharmaceutical giant Merck & Co., Inc., was competing for a billion-dollar expansion in Elkton, a town in the Shenandoah Valley.

The highly transmissible omicron variant of the novel coronavirus upended perceptions about proper mitigation. People who had been wearing fabric masks began switching over to N95 and KN95 respirators, leading to greater demand for respirators.

During the COVID-19 pandemic, Virginia Tech's Rob Gourdie was busy investigating how to deliver medications more effectively.

Kimberly Kelly was a biomedical engineer at the University of Virginia (UVA), working on ways to diagnose pancreatic cancer, when she discovered a protein expressed by the cancer cells.

Universities, VA Bio+Tech Park Draw Investment to Richmond For communities seeking to recreate the success of well-known life sciences clusters in Boston, San Diego, and the San Francisco Bay Area, Genetic Engineering & Biotechnology News suggests there’s a straightforward formula to replicate.

Northern Virginia’s advantages in attracting talent are well known, from best-in-class public schools, to vibrant communities, to the attractions and sights of Washington, D.C.

When executives at Traditional Medicinals decided to build an East Coast manufacturing and processing operation, they cast a wide net.

Despite facing an unprecedented global pandemic, executives at GlaxoSmithKline Consumer Healthcare (GSK) were able to recruit 150 new employees for the company’s research and development center in Richmond.

Like many medical device startups, Luminoah began with a bright idea brought about by a personal need. In 2019, founder Neal Piper’s young son, Noah, had a medical issue that necessitated the use of a feeding tube.

Chandra Briggman is president and CEO of Activation Capital, an independent authority that supports life sciences and advanced technology companies and entrepreneurship in the Richmond area.

John Newby is CEO of Virginia Bio, the nonprofit statewide trade association that serves and promotes the life sciences industry in the Commonwealth.

Richmond and Petersburg Host a New Pharmaceutical Cluster Making Essential Medicines With Innovative Techniques The COVID-19 pandemic has brought shortages of all kinds to the U.S. economy, from cream cheese and toilet paper to N95 masks and consumer electronics.

Kollmorgen Ramps Up Production to Support Global COVID-19 Response Employees at Kollmorgen's Radford facilities go to work each day knowing they’re helping to save lives as the world faces the COVID-19 crisis.

Dr. Katherine A. Rowe is the 28th president of William & Mary, a position she’s held since 2018 after serving as provost and dean of faculty at Smith College in Massachusetts.

Kevin Scott is chief technology officer and executive vice president, technology and research, at Microsoft, and the author of the 2020 book “Reprogramming the American Dream: From Rural America to Silicon Valley — Making AI Serve Us All,” which discusses how artificial intelligence can promote growth and benefit all of society.

Rita McClenny is president and CEO of the Virginia Tourism Corporation (VTC), the agency tasked with expanding domestic and international inbound travel and motion picture production in Virginia.

Van Manufacturer Utilizes Virginia Talent Accelerator Program to Quickly Build Workforce In the competitive arena of economic development decision-making, answering the “Where are we going?” question leads to an equally critical query: “How fast can we get there?”